AbbVie Inc.

ABBV.NE·Cboe CA·Healthcare
Compare
40.84+0.95 (+2.38%)today
At close: Nov 4, 3:57 PM EST · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close39.89
Open39.80
Day range39.8040.84
52-week range23.6840.84
Off day high0.00%
Off 52-week high0.00%
Volume1.10K
Avg. volume (3M)12.62K
Market cap712.59B
EPS (TTM)0.1900
Forward P/E—
P/E ratio (TTM)214.95
Dividend yield2.95% (0.9500)
Beta (5Y)0.35
Shares outstanding16.70B
Short interest0.00% of float
Earnings dateJul 23, 2025
Analyst target—
Profit margin4.00%

Against its peers

Compare in full ›
ABBV.NE BMY LLY AMGN BIIB PFE.NE
Market cap 712.59B 131.21B 1.26T 258.68B 37.61B 237.39B
P/E (TTM) 214.9 14.2 46.0 27.7 110.2 17.1
Forward P/E — 9.6 28.3 19.5 15.6 —
Price/book -19.8 5.6 31.4 18.0 2.0 0.6
Dividend yield 2.95% 3.93% 0.49% 2.11% — 6.79%
1-year change +24.96% +37.66% +51.26% +51.61% +62.35% −8.50%
Today +2.38% +4.02% +0.61% +3.73% +2.22% +2.55%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All ABBV.NE news ›
Markets Daily·Positive

AbbVie (NYSE:ABBV) Price Target Raised to $338.00

Posted by Sarita Garza on Nov 5th, 2026 AbbVie (NYSE:ABBV – Free Report) had its price objective increased by Canaccord Genuity Group from $290.00 to $338.00 in a research report report published on Monday morning, Marketbeat reports. The…

PMLiVE··2 outletsPositive

AbbVie expands Oxford R&D as part of more than £120m investment in UK life sciences

PMLiVE AbbVie expands Oxford R&D as part of more than £120m investment in UK life sciences AbbVie has announced the expansion of its UK R&D facility, AbbVie Oxford. The new 12,000-square-foot site will expand AbbVie

More from 1 other outlet
The Globe and Mail·Negative

AbbVie (ABBV) Receives a Rating Update from a Top Analyst

Leerink Partners analyst David Risinger reiterated a Buy rating on AbbVie today and set a price target of $325.00. According to TipRanks, Risinger is a top 100 analyst with an average return of 32.8% and a 65.44% success rate. Risinger…

From the 4Search news index, newest first.

In the news

293mentions in 30 days
251with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance